StudyFinder
Standardized Microbiota Transplant Therapy in Crohn's Disease
Status: Recruiting
The goal of this study is to determine if healthy donor microbes released in the small intestine act the same way as healthy donor microbes released in the large intestine for people with Crohn's Disease. We will see what good bacteria are present in intestinal biopsies at 8 weeks and look for improvement in inflammation with colonoscopy.
Sex: Male or Female
Age Group: 18 years and over
Inclusion Criteria:
• 18 to 89 years old
• English speaking
• Diagnosis of Crohn's Disease (CD)
• Current CD therapies are in the maintenance phase of dosing
• Women who could become pregnant must remain abstinent or use a highly effective form of birth control (e.g., oral contraception, transdermal patch, barrier, intrauterine device)
• See link to clinicaltrials.gov for complete inclusion and exclusion criteria
Exclusion Criteria:
• Extensive bowel resection or ileostomy or colostomy
• Diagnosis of ulcerative colitis
• Women who are pregnant or breastfeeding
• History of anaphylactic food allergies
Conditions:
Digestive & Liver Health
Keywords:
Clinics and Surgery Center (CSC), Crohn's Disease, Fecal Microbiota, Gut bacteria, CD
Study Contact: Amanda Kabage - kaba0012@umn.edu
Principal Investigator: Byron Vaughn
Phase: PHASE2
IRB Number: STUDY00023114
See this study on ClinicalTrials.gov